# Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy

> **NCT01394848** · PHASE4 · TERMINATED · sponsor: **Yonsei University** · enrollment: 1 (actual)

## Conditions studied

- Stable Angina

## Interventions

- **DEVICE:** Endothelial cell capture stent with 1 month clopidogrel
- **DEVICE:** Everolimus eluting stent with 12 month clopidogrel
- **DRUG:** Atorvastatin 20mg loading
- **DRUG:** Atorvastatin 80mg loading

## Key facts

- **NCT ID:** NCT01394848
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Previous other study including EPC capture stent raised the issue of safety (significant high incidence of instent restenosis)
- **Last updated:** 2013-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394848, "Safety and Efficacy Study of Endothelial Progenitor Cell Capture Stent With 1 Months Dual Antiplatelet Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01394848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*